| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.41 | 0.03 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.35 | 0.05 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.29 | 0.07 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.29 | 0.2 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.28 | 0.08 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.28 | 0.09 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.24 | 0.4 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.23 | 0.3 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.23 | 0.3 |